Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J3VX
|
|||
Former ID |
DNC007545
|
|||
Drug Name |
1-(isoquinolin-5-yl)-3-(4-morpholinobenzyl)urea
|
|||
Synonyms |
Isoquinoline Analogue, 35; CHEMBL231105; SCHEMBL4023640; BDBM20341; LAJBRLBYOVKUOY-UHFFFAOYSA-N; N-5-isoquinolinyl-N'-[4-(4-morpholinyl)benzyl]urea; N-isoquinolin-5-yl-N'-[(4-morpholin-4-ylphenyl)methyl]urea
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H22N4O2
|
|||
Canonical SMILES |
C1COCCN1C2=CC=C(C=C2)CNC(=O)NC3=CC=CC4=C3C=CN=C4
|
|||
InChI |
1S/C21H22N4O2/c26-21(24-20-3-1-2-17-15-22-9-8-19(17)20)23-14-16-4-6-18(7-5-16)25-10-12-27-13-11-25/h1-9,15H,10-14H2,(H2,23,24,26)
|
|||
InChIKey |
LAJBRLBYOVKUOY-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Transient receptor potential cation channel V1 (TRPV1) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Inflammatory mediator regulation of TRP channels | ||||
NetPath Pathway | IL2 Signaling Pathway | |||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | |||
Trk receptor signaling mediated by PI3K and PLC-gamma | ||||
Reactome | TRP channels |
References | Top | |||
---|---|---|---|---|
REF 1 | In vitro structure-activity relationship and in vivo characterization of 1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1 ... J Med Chem. 2007 Jul 26;50(15):3651-60. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.